FdaApplication
NDA 220201
Identifiers
- fda_app_no: NDA220201
Properties
| Property | Value |
|---|---|
| applicant_name | AVYXA HOLDINGS LLC |
| application_type | NDA |
| approval_date | 2026-02-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FAVLYXA | FLUOROURACIL | 2.5GM/100ML (25MG/ML) | SOLUTION;INTRAVENOUS |
| FAVLYXA | FLUOROURACIL | 250MG/10ML (25MG/ML) | SOLUTION;INTRAVENOUS |
2 products